ELYSIUM BIOSCIENCES

Serial Number 87748621
606

Registration Progress

Application Filed
Jan 9, 2018
Under Examination
Jan 29, 2019
Approved for Publication
Dec 4, 2018
Published for Opposition
Dec 4, 2018
Registered

Trademark Image

ELYSIUM BIOSCIENCES

Basic Information

Serial Number
87748621
Filing Date
January 9, 2018
Published for Opposition
December 4, 2018
Abandonment Date
March 7, 2022
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 7, 2022
Classes
005 042

Rights Holder

Elysium Health, Inc.

03
Address
434 Broadway, Floor 2
New York, NY 10013

Ownership History

Elysium Health, Inc.

Original Applicant
03
New York, NY

Elysium Health, Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Aaron Y. Silverstein

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

39 events
Date Code Type Description Documents
Mar 7, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Mar 7, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 16, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 15, 2021 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 15, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 9, 2021 EXT5 S SOU EXTENSION 5 FILED Loading...
Jun 9, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 22, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 20, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 20, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 20, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 21, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 17, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 17, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 17, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 7, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 3, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 3, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 3, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 11, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 9, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 9, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 9, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 29, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 4, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 4, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 14, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 1, 2018 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Oct 31, 2018 ALIE A ASSIGNED TO LIE Loading...
Oct 17, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 16, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 15, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 15, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 18, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 18, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 18, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 18, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 23, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 12, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for the treatment, or prevention, of aging or age-related disorders or diseases; Pharmaceuticals for the treatment, or prevention, of neurodegenerative diseases or disorders
Class 042
Pharmaceutical research and development services

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCES"